<DOC>
	<DOCNO>NCT02291211</DOCNO>
	<brief_summary>This study design investigate efficacy S-1 plus cisplatin hyperthermic intraperitoneal chemotherapy advance gastric patient gastric cytoreductive surgery ( CRS )</brief_summary>
	<brief_title>S-1 Combined Cisplatin HIPEC Palliative Operation Gastric Cancer Stage IV Limited Peritoneal Metastasis</brief_title>
	<detailed_description>This project single-center , open clinical observation safety efficacy stage IV limit peritoneal metastasis gastric cancer patient accept S-1 plus hyperthermic intraperitoneal chemotherapy . With advanced gastric patient confine peritoneal CRS research object , progression-free survival overall survival , adverse event end point .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>18 ≤ age ≤ 70 year old Patients histologically confirm gastric cancer ( adenocarcinoma ) , stage IV ( limited abdominal cavity ) , accpeted palliative cytoreductive surgery prior chemotherapy , biological therapy target anticancer therapy , etc . The Eastern Cooperative Oncology Group ( ECOG ) status ≤ 2 Having give write informed consent prior procedure relate study Expected survival time ≥3 month Known abdominal viscera metastasis gastric cancer patient Inadequate hematopoietic function define : white blood cell ( WBC ) less 3,500/mm^3 absolute neutrophil count ( ANC ) less 1,500/mm^3 platelet less 80,000/mm^3 Inadequate hepatic renal function define : serum bilirubin great 2 time upper limit normal range alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) great 2.5 time ULN demonstrable liver metastasis great 5 time ULN presence liver metastases blood creatinine level great 1.5 time ULN , Creatinine clearance &lt; 60ml/min Receiving concomitant treatment fluoropyrimidine drug flucytosine drug Women pregnant lactate fertile woman childbearing potential unless use reliable appropriate contraceptive method throughout treatment period ( Including male ) Psychiatric disorder symptom make participation patient difficult Myocardial infarction , exist serious unstable angina , patient cardiac insufficiency 6 month Severe complication ( ) , e.g. , paresis intestine , ileus , radiographically confirm interstitial pneumonitis pulmonary fibrosis , glomerulonephritis , renal failure , poorlycontrolled diabetes Known DPD deficiency Have history allograft transplantation Conducted autologous bone marrow transplantation 4 week Participate clinical trial start trial 4 week Patient compliance bad researcher believe patient suitable treatment Known active hepatitis patient HER2positive patient ( ICH3+or FISH+ ) History severe hypersensitivity reaction ingredient S1 Cisplatin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>